Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Leucomycin analogues reported by Meiji Seika

Sep. 3, 1997

Carbohydrate-based antimicrobial agents from Novo Nordisk

Sep. 3, 1997

Novel antimicrobial agents discovered by Ortho

Sep. 2, 1997

FDA approves Gensia's injectable acyclovir

Aug. 29, 1997

Faulding's generic acyclovir receives FDA approval

Aug. 29, 1997

Marketing agreement reached for Abelcet in France and Italy

Aug. 28, 1997

BMS reports new cephalosporins active against MRSA

Aug. 28, 1997

Data sheet for Lariam updated

Aug. 27, 1997

RespiGam approved for marketing in Canada

Aug. 25, 1997

Supplemental NDA approved for Cipro

Aug. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...